Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease
- 30 April 2007
- journal article
- review article
- Published by Elsevier in Brain Research Bulletin
- Vol. 72 (2-3) , 152-158
- https://doi.org/10.1016/j.brainresbull.2006.10.028
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Interrater agreement in the assessment of motor manifestations of Huntington's diseaseMovement Disorders, 2005
- Caudate volume as an outcome measure in clinical trials for Huntington’s disease: a pilot studyBrain Research Bulletin, 2003
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Regional Specificity of Brain Atrophy in Huntington's DiseaseExperimental Neurology, 1998
- When does Huntington's disease begin?Journal of the International Neuropsychological Society, 1998
- Longitudinal change in basal ganglia volume in patients with Huntington's diseaseNeurology, 1997
- Basal Ganglia Volume and Proximity to Onset in Presymptomatic Huntington DiseaseArchives of Neurology, 1996
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996
- Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15Human Molecular Genetics, 1993
- Trinucleotide repeat length instability and age of onset in Huntington's diseaseNature Genetics, 1993